UBS ASSET MANAGEMENT AMERICAS INC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,350,066
-40.6%
115,489
-15.7%
0.00%0.0%
Q2 2023$2,272,7360.0%137,0770.0%0.00%0.0%
Q1 2023$2,272,736
-3.8%
137,077
+8.0%
0.00%0.0%
Q4 2022$2,361,289
-99.8%
126,951
+4.8%
0.00%0.0%
Q3 2022$1,554,188,000
+81.8%
121,137
-0.7%
0.00%
Q2 2022$854,996,000
-18.0%
121,968
-3.0%
0.00%
Q1 2022$1,042,533,000
-6.5%
125,758
-23.6%
0.00%
Q4 2021$1,114,735,000
+52.8%
164,658
+19.6%
0.00%
Q3 2021$729,677,000
-37.3%
137,675
-32.0%
0.00%
Q2 2021$1,164,231,000
+29.5%
202,475
+3.8%
0.00%
Q1 2021$898,955,000
+38.0%
195,0010.0%0.00%
Q4 2020$651,303,000
+125.4%
195,001
+100.4%
0.00%
Q3 2020$288,984,000
-37.5%
97,301
-2.8%
0.00%
Q2 2020$462,707,000
+19.4%
100,153
-0.5%
0.00%
Q1 2020$387,476,000
+10.2%
100,643
+7.3%
0.00%
Q4 2019$351,608,000
-38.4%
93,762
-12.8%
0.00%
Q3 2019$570,936,000
+94.7%
107,521
+40.8%
0.00%
Q2 2019$293,272,00076,3730.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders